Conduct disorder

Recommendations

Info

Katarina Stavri] telite i decata dovede do zna~itelno podobruvawe na objektivnite simptomi i podobren kvalitet na ìvot. Vo odnos na primarnata prevencija ne postojat dokazi za preventiven efekt na ekskluzivno doewe, izbegnuvawe aerolaergeni, rano vnesuvawe hrana, izbegnuvawe odredena hrana od strana na majkata. Postojat dokazi deka terapija so probiotici na majkata vo tekot na bremenosta i vo prvite meseci po ra\aweto odloùva pojava na AD. Sekundarna prevencija se sostoi vo izbegnuvawe i redukcija na identifikuvanite triger faktori i dobra nega na koàta. Prevencijata se sproveduva individualno za sekoj pacient poedine~no. Treba da se bide vnimatelen pri sproveduvawe eliminacioni dieti osobeno vo ranata detska vozrast. Eliminacionata dieta treba da se bazira vrz napraven dvojno slep placebo kontroliran test na provokacija. Ako postoi senzibilizacija na doma[na pra[ina se prepora~uvaat odredeni merki za namaluvawe. Novite soznanija za va`nosta na integritetot na ko`nata bariera i ulogata na imuniot odgovor go podobrija vodeweto na pacientite, kako i tokot i prognozata na AD. Deneska doktorite imaat razni terapiski mo`nosti vo terapijata na ovaa sostojba i kontrola na egzecerbaciite, no ne moè da se ile~i. Primenata na sistemski imunosupresivni terapii ostanuva predmet na idni istraùvawa. Literatura: 1. Leung D.Y. New insigts into atopic dermatitis. The Journal of Clinical investigation 2004:113(5):651-657. 2. Bieber T Atopic Dermatitis N Eng J Med 2008;358:1483-94 3. Weller R, McLean WHI Filaggrin and eczema J R Coll Physicians Edinb 2008;38:45-7 4. F.Rance, M.Boguniewicz, S.Lau New vision for atopic eczema: An iPAC summary and future trends PAI 2008;19:17-25. 5. Leung DYM Current Opinion in immunology 2003-10 6. Barker JN, Palmer CN, Zhao Y, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol. 2007;127:564–567. 7. Elias PM Barrier-repair therapy for atopic dermatitis: corrective lipid biochemical therapy. Expert Rev Dermatol 2008;3(4)441-452 8. Grimalt, R, Mengeaud, V, Cambazard, F. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214:61. Страна 202
Novini vo pedijatrijata / Godi[na revija 2009 9. Orlow SJ. Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues. Paediatr Drugs. 2007;9:289–299. 10. Berth-Jones, J, Damstra, RJ, Golsch, S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326:1367. 11. Lane, JE, Cheyney, JM, Lane, TN, et al. Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol 2006; 54:68. 12. Weinberg, JM, Siegfried, EC. Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab. Arch Dermatol 2006; 142:555. 13. Simon, D, Hosli, S, Kostylina, G, et al. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol 2008; 121:122. 14. Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332:933–938. Страна 203
Page 1 and 2:
NOVINI VO PEDIJATRIJATA GODI{NA REV
Page 3:
Od glavniot redaktor Po~ituvani kol
Page 6 and 7:
Mladenović M, Radlović N, Lekovi
Page 8 and 9:
Milena C. Lo Giudice Although all t
Page 10 and 11:
Milena C. Lo Giudice patient will h
Page 12 and 13:
Milena C. Lo Giudice have on the ch
Page 14 and 15:
Страна 14
Page 16 and 17:
Nedeqko Radlovi] nje. Budući da su
Page 18 and 19:
Nedeqko Radlovi] (maksimalno 15 mg
Page 20 and 21:
Gjeorgjina Kuli-Lito Introduction K
Page 22 and 23:
Gjeoorgjina Kuli-Liito The fever ty
Page 24 and 25:
Gjeorgjina Kuli-Lito stenoses in ch
Page 26 and 27:
Страна 26
Page 28 and 29:
@eqko Ron~evi] Will stethoscope sur
Page 30 and 31:
@eqko Ron~evi] Electronic stethosco
Page 32 and 33:
@eqko Ron~evi] 8. Mangione S, Duffy
Page 34 and 35:
Nada Pop-Jordanova a critical role
Page 36 and 37:
Nada Pop-Jordanova response (long-t
Page 38 and 39:
Nada Pop-Jordanova In the following
Page 40 and 41:
Nada Pop-Jordanova From Fig. 4 it i
Page 42 and 43:
Nada Pop-Jordanova References: [1]
Page 44 and 45:
Nada Pop-Jordanova [22] Friesen GM,
Page 46 and 47:
Mirjana Ko~ova Ha[imoto tiroiditis
Page 48 and 49:
Mirjana Ko~ova Slika 2. Devoj~e na
Page 50 and 51:
Mirjana Ko~ova c) Ultrazvu~niot pre
Page 52 and 53:
Mirjana Ko~ova smetaat deka kaj ovi
Page 54 and 55:
Mirjana Ko~ova 10. Pituitary pseudo
Page 56 and 57:
Страна 56
Page 58 and 59:
Qup~o Nikolovski Summary: Regardles
Page 60 and 61:
Qup~o Nikolovski Sugeriran antibiot
Page 62 and 63:
Qup~o Nikolovski - Toj moè da se k
Page 64 and 65:
Qup~o Nikolovski Sugeriran reìm Pr
Page 66 and 67:
Qup~o Nikolovski decata so akcent n
Page 68 and 69:
Qup~o Nikolovski Antibiotici i dija
Page 70 and 71:
Страна 70
Page 72 and 73:
Sowa Peova Abstrakt Efikasno rano o
Page 74 and 75:
Sowa Peova Ranoto klini~ko prepozna
Page 76 and 77:
Sowa Peova - In vitro analiza na in
Page 78 and 79:
Sowa Peova metodi pred da se pojava
Page 80 and 81:
Sowa Peova Страна 80
Page 82 and 83:
Страна 82
Page 84 and 85:
Dafina Kuzmanovska bubre`na insufic
Page 86 and 87:
Dafina Kuzmanovska 1. Abnormalen ra
Page 88 and 89:
Dafina Kuzmanovska Isto taka, nema
Page 90 and 91:
Dafina Kuzmanovska 11. Feather AS,
Page 92 and 93:
Aco Kostovski na holestaza ne se pr
Page 94 and 95:
Aco Kostovski dukcijata na SREBP -
Page 96 and 97:
Aco Kostovski niraat sintezata na l
Page 98 and 99:
Aco Kostovski lema neselektirana st
Page 100 and 101:
Aco Kostovski 2. Tip 1 ili 2 diabet
Page 102 and 103:
Aco Kostovski parcijalna lipodistro
Page 104 and 105:
Aco Kostovski patis od drugi mo`ni
Page 106 and 107:
Aco Kostovski Lipoproteini so mala
Page 108 and 109:
Aco Kostovski kontrola na obeznosta
Page 110 and 111:
Aco Kostovski za razlika od general
Page 112 and 113:
Aco Kostovski NEALKOHOLNA MASTNA BO
Page 114 and 115:
Lekovi] Z. SY GILBERT IN CHILDREN:
Page 116 and 117:
Страна 116
Page 118 and 119:
Aspazija Sofijanova ABSTRAKT Mnogu
Page 120 and 121:
Aspazija Sofijanova en~iwa. Zatoa d
Page 122 and 123:
Aspazija Sofijanova Odgovor na Krat
Page 124 and 125:
Aspazija Sofijanova cira so seriozn
Page 126 and 127:
Aspazija Sofijanova sporo. Hepati~n
Page 128 and 129:
Aspazija Sofijanova asociran so pos
Page 130 and 131:
Aspazija Sofijanova 16. Meyer PG, O
Page 132 and 133:
Aspazija Sofijanova 48. Goldman HB.
Page 134 and 135:
Страна 134
Page 136 and 137:
Du[ko Fidanovski Abstract With intr
Page 138 and 139:
Du[ko Fidanovski dilna teìna od 50
Page 140 and 141:
Du[ko Fidanovski koncentracii pomal
Page 142 and 143:
Du[ko Fidanovski Lekuvawe so surfak
Page 144 and 145:
Du[ko Fidanovski EMRT i golem rizik
Page 146 and 147:
Du[ko Fidanovski 17. Kotecha S, Wil
Page 148 and 149:
Du[ko Fidanovski 46. Corbet A, Long
Page 150 and 151:
Страна 150
Page 152 and 153: Filip Duma fluid. Precise diagnose
Page 154 and 155: Filip Duma rata i mozo~noto tkivo,
Page 156 and 157: Filip Duma Diskusija i rezultati: K
Page 158 and 159: Kata Martinova endokrinite `lezdi i
Page 160 and 161: Kata Martinova Evaluacija i monitor
Page 162 and 163: Kata Martinova SQUID (superconducti
Page 164 and 165: Kata Martinova sostojba da odrùva
Page 166 and 167: Kata Martinova 10. Grady RW., Berdo
Page 168 and 169: Vladimir âdikovski The computer th
Page 170 and 171: Vladimir âdikovski 5. Should peopl
Page 172 and 173: Nadica Ristoska Bojkovska Istorijat
Page 174 and 175: Nadica Ristoska Bojkovska � Virus
Page 176 and 177: Nadica Ristoska Bojkovska na CMV in
Page 178 and 179: Nadica Ristoska Bojkovska Takrolimu
Page 180 and 181: Nadica Ristoska Bojkovska Literatur
Page 182 and 183: Velibor Tasi] Hipourikemija e labor
Page 184 and 185: Velibor Tasi] Ovoj lek go zgolemuva
Page 186 and 187: Velibor Tasi] diabetes mellitus, ma
Page 188 and 189: Страна 188
Page 190 and 191: Emilija Vla[ki diagnostic investiga
Page 192 and 193: Emilija Vla[ki pnevmociti so difuzn
Page 194 and 195: Emilija Vla[ki dijagnosti~koto zna~
Page 196 and 197: Emilija Vla[ki na~eni promeni treba
Page 198 and 199: Katarina Stavri] na prisustvoto na
Page 200 and 201: Katarina Stavri] fagite i eozinofil
Page 204 and 205: Страна 204
Page 206 and 207: Katerina Obo~ki What is the Practal
Page 208 and 209: Katerina Obo~ki Tret fakt: izloèno
Page 210 and 211: Katerina Obo~ki - izbegnuvawe na ek
Page 212: Katerina Obo~ki Zaklu~ok: Sekoga[ t
show all

Conduct disorder

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?